SEP
TMO icon

Signature Equity Partners’s Thermo Fisher Scientific TMO Stock Holding History

Signature Equity Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Buy
43
+3
+8% +$1.44K 0.01% 625
2026
Q1 		$19.8K Sell
40
-5
-11% -$2.71K 0.01% 635
2025
Q4 		$26.3K Buy
+45
New +$25.4K 0.01% 564

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Signature Equity Partners's TMO Position: Q2 2026 in Review

Signature Equity Partners increased its Thermo Fisher Scientific (TMO) stake by 7.5% in Q2 2026, buying an estimated $1.44K and bringing the position to 43 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #625.

Signature Equity Partners first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.3K in Q4 2025. 2,616 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Signature Equity Partners held 43 shares of Thermo Fisher Scientific worth $21.8K as of Q2 2026.
  • Signature Equity Partners bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #625 holding.
  • Signature Equity Partners first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Thermo Fisher Scientific position peaked at $26.3K in Q4 2025.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.